Granules India Navigates Profit Dip, Eyes Future Growth Through Product Pipeline Strength
Granules India Navigates Profit Dip, Eyes Future Growth Through Product Pipeline Strength Company remains optimistic about long-term prospects despite short-term financial headwinds. Granules India, a pharmaceutical company, is facing a period of adjustment following a reported decline in profits for the June quarter. However, market observers and company management are pointing to a robust product pipeline as a potential catalyst…
